4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-20-006793
Director sold 5,023 shares at an average $306.62 ($1,540,167)
- Director acquired 5,023 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seth Alpna Director | 2020-11-09 | Option exercise | +1,898 | $179.84 | $341,336 | 4,037 | D |
| Seth Alpna Director | 2020-11-09 | Option exercise | +3,125 | $125.05 | $390,781 | 7,162 | D |
| Seth Alpna Director | 2020-11-09 | Sale | −1,358 | $305.74 | $415,195 | 5,804 | D |
| Seth Alpna Director | 2020-11-09 | Sale | −3,665 | $306.95 | $1,124,972 | 2,139 | D |
| Derivatives | |||||||
| Seth Alpna Director | 2020-11-09 | Option exercise · Stock Option (Right to Buy) | −1,898 | 0 | D | ||
| Seth Alpna Director | 2020-11-09 | Option exercise · Stock Option (Right to Buy) | −3,125 | 0 | D | ||
| Open-market sales · 5,023 sh · avg $306.62 · $1,540,167 | |||||||
Loading xslF345X03/primarydocument.xml…